Upregulating nonneuronal cholinergic activity decreases TNF release from lipopolysaccharide-stimulated RAW264.7 cells

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Lv, Yi ^a   Hu, Sen ^a   Lu, Jiangyang ^a   Dong, Ning ^a   Liu, Qian ^a   Du, Minghua ^a   Zhang, Huiping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BETA ACTIN; BUNGAROTOXIN RECEPTOR; CHOLINE ACETYLTRANSFERASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CULTURE MEDIUM;

ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; GENETIC TRANSFECTION; MACROPHAGE; MOUSE; NONHUMAN; NONNEURONAL CHOLINERGIC ACTIVITY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; CELL LINE; CELL SEPARATION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; FLOW CYTOMETRY; METABOLISM; TIME;

ACETYLCHOLINE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SEPARATION; CHOLINE O-ACETYLTRANSFERASE; CULTURE MEDIA; FLOW CYTOMETRY; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897532224     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/873728     Document Type: Article

References (53)

1. Morris D., The choline acetyltransferase of human placenta. Biochemical Journal 1966 98 3 754 762 2-s2.0-0013888016
2. Lan C.-T., Shieh J.-Y., Wen C.-Y., Tan C.-K., Ling E.-A., Ultrastructural localization of acetylcholinesterase and choline acetyltransferase in oligodendrocytes, glioblasts and vascular endothelial cells in the external cuneate nucleus of the gerbil. Anatomy and Embryology 1996 194 2 177 185 2-s2.0-0029662065
3. Wessler I., Reinheimer T., Klapproth H., Schneider F.-J., Racké K., Hammer R., Mammalian glial cells in culture synthesize acetylcholine. Naunyn-Schmiedeberg's Archives of Pharmacology 1997 356 5 694 697 2-s2.0-0030709466 10.1007/PL00005107 (Pubitemid 27478974)
4. Fujii T., Tsuchiya T., Yamada S., Fujimoto K., Suzuki T., Kasahara T., Kawashima K., Localization and synthesis of acetylcholinein human leukemic T cell lines. Journal of Neuroscience Research 1996 44 66 72 (Pubitemid 26111111)
5. Zia S., Ndoye A., Lee T. X., Webber R. J., Grando S. A., Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. Journal of Pharmacology and Experimental Therapeutics 2000 293 3 973 981 2-s2.0-0034126719 (Pubitemid 30417866)
6. Nguyen V. T., Hall L. L., Gallacher G., Ndoye A., Jolkovsky D. L., Webber R. J., Buchli R., Grando S. A., Choline acetyltransferase, acetylcholinesterase, and nicotinic acetylcholine receptors of human gingival and esophageal epithelia. Journal of Dental Research 2000 79 4 939 949 2-s2.0-0034438346 (Pubitemid 32501305)
7. Klapproth H., Reinheimer T., Metzen J., Münch M., Bittinger F., Kirkpatrick C. J., Höhle K.-D., Schemann M., Racké K., Wessler I., Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn-Schmiedeberg's Archives of Pharmacology 1997 355 4 515 523 2-s2.0-8044224009 10.1007/PL00004977 (Pubitemid 27140478)
8. Conti-Fine B. M., Navaneetham D., Lei S., Maus A. D. J., Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? European Journal of Pharmacology 2000 393 1-3 279 294 2-s2.0-0034732218 10.1016/S0014-2999(00)00036-4 (Pubitemid 30193427)
9. Sharma G., Vijayaraghavan S., Nicotinic receptor signaling in nonexcitable cells. Journal of Neurobiology 2002 53 4 524 534 2-s2.0-0036891170 10.1002/neu.10114 (Pubitemid 35375583)
10. Wessler I., Kirkpatrick C. J., Racké K., Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacology and Therapeutics 1998 77 1 59 79 2-s2.0-0031964633 10.1016/S0163-7258(97)00085-5 (Pubitemid 28059940)
11. Wessler I., Kilbinger H., Bittinger F., Unger R., Kirkpatrick C. J., The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sciences 2003 72 18-19 2055 2061 2-s2.0-0037470640 10.1016/S0024-3205(03)00083-3 (Pubitemid 36298947)
12. Wessler I., Kirkpatrick C. J., Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. British Journal of Pharmacology 2008 154 8 1558 1571 2-s2.0-49449094458 10.1038/bjp.2008.185
13. Hecker A., Mikulski Z., Lips K. S., Pfeil U., Zakrzewicz A., Wilker S., Hartmann P., Padberg W., Wessler I., Kummer W., Grau V., Pivotal Advance: up-regulation of acetylcholine synthesis and paracrine cholinergic signaling in intravascular transplant leukocytes during rejection of rat renal allografts. Journal of Leukocyte Biology 2009 86 1 13 22 2-s2.0-68849084160 10.1189/jlb.1107722
14. Borovikova L. V., Ivanova S., Zhang M., Yang H., Botchkina G. I., Watkins L. R., Wang H., Abumrad N., Eaton J. W., Tracey K. J., Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000 405 6785 458 462 2-s2.0-0034713266 10.1038/35013070 (Pubitemid 30367422)
15. Kessler W., Traeger T., Westerholt A., Neher F., Mikulcak M., Müller A., Maier S., Heidecke C.-D., The vagal nerve as a link between the nervous and immune system in the instance of polymicrobial sepsis. Langenbeck's Archives of Surgery 2006 391 2 83 87 2-s2.0-33645775504 10.1007/s00423-006-0031-y
16. Wang H., Yu M., Ochani M., Amelia C. A., Tanovic M., Susarla S., Li J. H., Wang H., Yang N., Ulloa L., Al-Abed Y., Czura C. J., Tracey K. J., Nicotinic acetylcholine receptor α 7 subunit is an essential regulator of inflammation. Nature 2003 421 6921 384 388 2-s2.0-0037461768 10.1038/nature01339 (Pubitemid 36157937)
17. Pavlov V. A., Wang H., Czura C. J., Friedman S. G., Tracey K. J., The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Molecular Medicine 2003 9 5-8 125 134 2-s2.0-0142178155 (Pubitemid 37310949)
18. Biswas S. K., Lopez-Collazo E., Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends in Immunology 2009 30 10 475 487 2-s2.0-70349559403 10.1016/j.it.2009.07.009
19. West M. A., Heagy W., Endotoxin tolerance: a review. Critical Care Medicine 2002 30 1 S64 S73 2-s2.0-0036159842 (Pubitemid 34131164)
20. Virca G. D., Kim S. Y., Glaser K. B., Ulevitch R. J., Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. Journal of Biological Chemistry 1989 264 36 21951 21956 2-s2.0-0024842903 (Pubitemid 20028773)
21. West M. A., Koons A., Endotoxin tolerance in sepsis: concentration- dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment. The Journal of Trauma 2008 65 4 893 898 2-s2.0-56149089437
22. Li J., Mathieu S. L., Harris R., Ji J., Anderson D. J., Malysz J., Bunnelle W. H., Waring J. F., Marsh K. C., Murtaza A., Olson L. M., Gopalakrishnan M., Role of α 7 nicotinic acetylcholine receptors in regulating tumor necrosis factor- α (TNF- α) as revealed by subtype selective agonists. Journal of Neuroimmunology 2011 239 1-2 37 43 2-s2.0-80054953383 10.1016/j.jneuroim.2011.08.007
23. Ellman G. L., Courtney K. D., Andres V. Jr., Featherstone R. M., A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961 7 2 88 95 2-s2.0-33644811612
24. Kopanakis K., Tzepi I. M., Pistiki A., Carrer D. P., Netea M. G., Georgitsi M., Lymperi M., Droggiti D. I., Liakakos T., Machairas A., Giamarellos-Bourboulis E. J., Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: Benefit for lethal peritonitis by Escherichia coli. Cytokine 2013 62 3 382 388
25. Murphey E. D., Fang G., Sherwood E. R., Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus. Shock 2008 29 4 512 518 2-s2.0-40949114220 10.1097/SHK.0b013e318150776f (Pubitemid 351416805)
26. Draisma A., Pickkers P., Bouw M. P. W. J. M., Van Der Hoeven J. G., Development of endotoxin tolerance in humans in vivo. Critical Care Medicine 2009 37 4 1261 1267 2-s2.0-67650433962 10.1097/CCM.0b013e31819c3c67
27. Evans G. F., Zuckerman S. H., Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance. European Journal of Immunology 1991 21 9 1973 1979 2-s2.0-0025779580
28. Cavaillon J.-M., Adib-Conquy M., Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Critical Care 2006 10 5, article 233 2-s2.0-34250869345 10.1186/cc5055 (Pubitemid 47086977)
29. Parrillo J. E., Mechanisms of disease: pathogenetic mechanisms of septic shock. The New England Journal of Medicine 1993 328 20 1471 1477 2-s2.0-0027920980 10.1056/NEJM199305203282008 (Pubitemid 23143850)
30. Limaye A. P., Kirby K. A., Rubenfeld G. D., Leisenring W. M., Bulger E. M., Neff M. J., Gibran N. S., Huang M.-L., Santo Hayes T. K., Corey L., Boeckh M., Cytomegalovirus reactivation in critically ill immunocompetent patients. Journal of the American Medical Association 2008 300 4 413 422 2-s2.0-47849130092 10.1001/jama.300.4.413 (Pubitemid 352040253)
31. Luyt C.-E., Combes A., Deback C., Aubriot-Lorton M.-H., Nieszkowska A., Trouillet J.-L., Capron F., Agut H., Gibert C., Chastre J., Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. American Journal of Respiratory and Critical Care Medicine 2007 175 9 935 942 2-s2.0-34247607201 10.1164/rccm.200609-1322OC (Pubitemid 46684704)
32. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., Akira S., Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. Journal of Immunology 2000 164 7 3476 3479 2-s2.0-20244384395 (Pubitemid 30169796)
33. Medvedev A. E., Piao W., Shoenfelt J., Sang H. R., Chen H., Basu S., Wahl L. M., Fenton M. J., Vogel S. N., Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. Journal of Biological Chemistry 2007 282 22 16042 16053 2-s2.0-34447525018 10.1074/jbc.M606781200 (Pubitemid 47100380)
34. Li L., Cousart S., Hu J., McCall C. E., Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. Journal of Biological Chemistry 2000 275 30 23340 23345 2-s2.0-0034725584 10.1074/jbc.M001950200 (Pubitemid 30646236)
35. Medvedev A. E., Lentschat A., Wahl L. M., Golenbock D. T., Vogel S. N., Dysregulation of LPS-induced toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. Journal of Immunology 2002 169 9 5209 5216 2-s2.0-0036838930 (Pubitemid 35217192)
36. Ziegler-Heitbrock H. W. L., Wedel A., Schraut W., Ströbel M., Wendelgass P., Sternsdorf T., Bäuerle P. A., Haas J. G., Riethmüller G., Tolerance to lipopolysaccharide involves mobilization of nuclear factor B with predominance of p50 homodimers. Journal of Biological Chemistry 1994 269 25 17001 17004 2-s2.0-0028229050 (Pubitemid 24204013)
37. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., Yoshimura A., SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002 17 5 583 591 2-s2.0-0036850946 10.1016/S1074-7613(02)00446-6 (Pubitemid 35351504)
38. Kobayashi K., Hernandez L. D., Galán J. E., Janeway C. A. Jr., Medzhitov R., Flavell R. A., IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002 110 2 191 202 2-s2.0-0037178785 10.1016/S0092-8674(02)00827-9 (Pubitemid 34876547)
39. Xiong Y., Medvedev A. E., Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20. Journal of Leukocyte Biology 2011 90 6 1141 1148 2-s2.0-82555193814 10.1189/jlb.0611273
40. Randow F., Syrbe U., Meisel C., Krausch D., Zuckermann H., Platzer C., Volk-H. D., Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β Journal of Experimental Medicine 1995 181 5 1887 1892 2-s2.0-0028906220
41. Nahid M. A., Pauley K. M., Satoh M., Chan E. K. L., miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. Journal of Biological Chemistry 2009 284 50 34590 34599 2-s2.0-71749096218 10.1074/jbc.M109.056317
42. LaRue K. E. A., McCall C. E., A labile transcriptional repressor modulates endotoxin tolerance. Journal of Experimental Medicine 1994 180 6 2269 2275 2-s2.0-0027967441 10.1084/jem.180.6.2269 (Pubitemid 24351608)
43. Kaufer D., Friedman A., Seidman S., Soreq H., Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 1998 393 6683 373 377 2-s2.0-0032574973 10.1038/30741 (Pubitemid 28269711)
44. Waiskopf N., Ofek K., Gilboa-Geffen A., Bekenstein U., Bahat A., Bennett E. R., Podoly E., Livnah O., Hartmann G., Soreq H., AChE and RACK1 promote the anti-inflammatory properties of fluoxetine. Journal of Molecular Neuroscience 2013 10.1007/s12031-013-0174-6
45. Shaked I., Meerson A., Wolf Y., Avni R., Greenberg D., Gilboa-Geffen A., Soreq H., MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Cell Signal 2001 13 2 85 94
46. Gilboa-Geffen A., Hartmann G., Soreq H., Stressing hematopoiesis and immunity: an acetylcholinesterase window into nervous and immune system interactions. Frontiers in Molecular Neuroscience 2012 5, article 30 1 10 2-s2.0-84859307724 10.3389/fnmol.2012.00030
47. Zimmerman G., Shaltiel G., Barbash S., Cohen J., Gasho C. J., Shenhar-Tsarfaty S., Shalev H., Berliner S. A., Shelef I., Shoham S., Friedman A., Cohen H., Soreq H., Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NF B pathway. Translational Psychiatry 2012 2, article e78 2-s2.0-84857167112 10.1038/tp.2012.4
48. Park S. E., Kim N. D., Yoo Y. H., Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Research 2004 64 8 2652 2655 2-s2.0-10844253547 10.1158/0008-5472.CAN-04-0649 (Pubitemid 38500595)
49. Zhang X. J., Yang L., Zhao Q., Caen J. P., He H. Y., Jin Q. H., Guo L. H., Alemany M., Zhang L. Y., Shi Y. F., Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death and Differentiation 2002 9 8 790 800 2-s2.0-0036024019 10.1038/sj.cdd.4401034
50. Guha M., Mackman N., LPS induction of gene expression in human monocytes. Immunity 2009 31 6 965 973
51. Mathison J. C., Virca G. D., Wolfson E., Tobias P. S., Glaser K., Ulevith R. J., Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide- induced tumor necrosis factor production in rabbit macrophages. Journal of Clinical Investigation 1990 85 4 1108 1118 2-s2.0-0025348273 (Pubitemid 20123752)
52. Chi Z.-L., Hayasaka S., Zhang X.-Y., Cui H.-S., Hayasaka Y., A cholinergic agonist attenuates endotoxin-induced uveitis in rats. Investigative Ophthalmology and Visual Science 2007 48 6 2719 2725 2-s2.0-34347223647 10.1167/iovs.06-0644 (Pubitemid 351261225)
53. Hamano R., Takahashi H. K., Iwagaki H., Yoshino T., Nishibori M., Tanaka N., Stimulation of α 7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes. Shock 2006 26 4 358 364 2-s2.0-33748745959 10.1097/01.shk.0000228168.86845.60 (Pubitemid 44402020)